632 related articles for article (PubMed ID: 18292996)
1. Tissue factor procoagulant activity of plasma microparticles in patients with cancer-associated disseminated intravascular coagulation.
Langer F; Spath B; Haubold K; Holstein K; Marx G; Wierecky J; Brümmendorf TH; Dierlamm J; Bokemeyer C; Eifrig B
Ann Hematol; 2008 Jun; 87(6):451-7. PubMed ID: 18292996
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
3. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
[TBL] [Abstract][Full Text] [Related]
4. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
[TBL] [Abstract][Full Text] [Related]
5. Plasma tissue factor and tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation.
Shimura M; Wada H; Wakita Y; Nakase T; Hiyoyama K; Nagaya S; Mori Y; Shiku H
Am J Hematol; 1996 Jul; 52(3):165-70. PubMed ID: 8756081
[TBL] [Abstract][Full Text] [Related]
6. Determination of plasma soluble fibrin using a new ELISA method in patients with disseminated intravascular coagulation.
Okajima K; Uchiba M; Murakami K; Okabe H; Takatsuki K
Am J Hematol; 1996 Mar; 51(3):186-91. PubMed ID: 8619398
[TBL] [Abstract][Full Text] [Related]
7. Non-overt disseminated intravascular coagulation scoring for critically ill patients: the impact of antithrombin levels.
Egi M; Morimatsu H; Wiedermann CJ; Tani M; Kanazawa T; Suzuki S; Matsusaki T; Shimizu K; Toda Y; Iwasaki T; Morita K
Thromb Haemost; 2009 Apr; 101(4):696-705. PubMed ID: 19350114
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer.
Hron G; Kollars M; Weber H; Sagaster V; Quehenberger P; Eichinger S; Kyrle PA; Weltermann A
Thromb Haemost; 2007 Jan; 97(1):119-23. PubMed ID: 17200778
[TBL] [Abstract][Full Text] [Related]
9. The tissue factor pathway in disseminated intravascular coagulation.
Østerud B; Bjørklid E
Semin Thromb Hemost; 2001 Dec; 27(6):605-17. PubMed ID: 11740684
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of pre-disseminated intravascular coagulation stage with hemostatic molecular markers. The Mie DIC Study Group.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Mori Y; Deguchi K; Shiku H
Pol J Pharmacol; 1996; 48(2):225-8. PubMed ID: 9112656
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of leukocyte tissue factor mRNA in patients with venous thromboembolism.
Kamikura Y; Wada H; Nobori T; Kobayashi T; Sase T; Nishikawa M; Ishikura K; Yamada N; Abe Y; Nishioka J; Nakano T; Shiku H
Thromb Res; 2005; 116(4):307-12. PubMed ID: 16038715
[TBL] [Abstract][Full Text] [Related]
12. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
13. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
[TBL] [Abstract][Full Text] [Related]
14. No interplay between the pathways mediating coagulation and inflammation in tissue factor-induced disseminated intravascular coagulation in rats.
Ontachi Y; Asakura H; Takahashi Y; Hayashi T; Arahata M; Kadohira Y; Maekawa M; Omote M; Yoshida T; Yamazaki M; Morishita E; Miyamoto K; Nakao S
Crit Care Med; 2006 Oct; 34(10):2646-50. PubMed ID: 16932226
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis and fibrinogenolysis in disseminated intravascular coagulation.
Takahashi H; Tatewaki W; Wada K; Niwano H; Shibata A
Thromb Haemost; 1990 Jun; 63(3):340-4. PubMed ID: 2402738
[TBL] [Abstract][Full Text] [Related]
16. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
17. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
Morel O; Morel N; Freyssinet JM; Toti F
Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
[TBL] [Abstract][Full Text] [Related]
18. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
[TBL] [Abstract][Full Text] [Related]
19. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
20. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
